REPL Competitors & Alternatives
Compare Replimune Group Inc with similar stocks in the same industry
Biotechnology
REPL
Main Stock$11.58
Tradestie Score
58
Market Cap
$328.62M
Analyst Upside
-7.9%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
|
$8.11
|
$952.74M | - | 64 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$4.01
|
$951.83M | - | 63 | Compare |
|
MNMD
Mind Medicine (MindMed) Inc. Common Shares
|
$15.02
|
$938.16M | - | 62 | Compare |
|
ZBIO
Zenas BioPharma, Inc. Common Stock
|
$27.23
|
$931.48M | - | 57 | Compare |
|
RLAY
Relay Therapeutics, Inc. Common Stock
|
$18.65
|
$917.23M | - | 62 | Compare |
|
OCS
Oculis Holding AG Ordinary shares
|
$14.12
|
$910.64M | - | 59 | Compare |
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$29.00
|
$906.29M | - | 59 | Compare |
|
NBTX
Nanobiotix S.A. American Depositary Shares
|
$38.40
|
$903.54M | - | 51 | Compare |
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$85.21
|
$900.91M | - | 60 | Compare |
|
GERN
Geron Corp
|
$1.36
|
$899.60M | - | 53 | Compare |
More REPL Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry